Legacy Financial Group, Inc. Dexcom Inc Transaction History

Legacy Financial Group, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$114.22 - $140.1 $1,599 - $1,961	-14 Reduced 0.82%	1,700 $236 Million
Q4 2023 Feb 13, 2024	BUY	$75.49 - $124.16 $129,389 - $212,810	1,714 New	1,714 $213 Million
Q2 2023 Aug 07, 2023	SELL	$112.47 - $130.98 $2,811 - $3,274	-25 Reduced 1.42%	1,739 $223 Million
Q1 2023 May 12, 2023	SELL	$104.0 - $122.92 $7,384 - $8,727	-71 Reduced 3.87%	1,764 $205 Million
Q4 2022 Feb 15, 2023	BUY	$84.98 - $122.67 $155,938 - $225,099	1,835 New	1,835 $208 Million

1,014

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $31B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Legacy Financial Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Legacy Financial Group, Inc. with notifications on news.